Amanta Healthcare Ltd

AI
Amanta Healthcar Summary Chart Analysis Peers Quarters Profit & Loss Balance Sheet Cash Flow Ratios Investors Documents
AI

Amanta Healthcare Ltd

₹ 196 4.98%
21 Aug - close price
amanta.co.in BSE: 544502 NSE: AMANTA
About

Incorporated in December 1994, Amanta Healthcare Limited is a pharmaceutical company that specializes in the development, manufacturing, and marketing of a diverse array of sterile liquid products.[1]

Key Points

Business Profile:[1][2]
Amanta Healthcare is a niche pharmaceutical company specializing in sterile liquid parenteral (injections and infusions) using ABFS and ISBM technologies. It operates across six therapeutic segments: fluid therapy, diluents and injectables, ophthalmic, respiratory solutions, irrigation, and other formulations.
As an integrated LVP and SVP manufacturer,
its products support critical care in oncology, pediatrics, ICU, and anesthesia. Under its “SteriPort” brand for two-port IV systems, management estimates a 50–60% domestic market share in PP IV bottles.

Website BSE NSE - BE
  • Market Cap ₹ 760 Cr.
  • Current Price ₹ 196
  • High / Low ₹ 196 / 92.0
  • Stock P/E 49.6
  • Book Value ₹ 56.7
  • Dividend Yield 0.00 %
  • ROCE 11.6 %
  • ROE 10.4 %
  • Face Value ₹ 10.0
Edit ratios

Pros

  • Company has delivered good profit growth of 22.4% CAGR over last 5 years

Cons

  • Stock is trading at 3.45 times its book value
  • Though the company is reporting repeated profits, it is not paying out dividend
  • The company has delivered a poor sales growth of 10.9% over past five years.
  • Company has a low return on equity of 10.1% over last 3 years.

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Healthcare Healthcare Pharmaceuticals & Biotechnology Pharmaceuticals

Edit Columns
Loading peers table ...

Quarterly Results

Figures in Rs. Crores

Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025 Sep 2025 Dec 2025 Mar 2026 Jun 2026
68.10 66.73 67.81 72.06 65.31 70.89 74.49 76.99 68.80
54.70 52.85 52.75 53.10 50.41 56.24 59.13 62.03 54.26
Operating Profit 13.40 13.88 15.06 18.96 14.90 14.65 15.36 14.96 14.54
OPM % 19.68% 20.80% 22.21% 26.31% 22.81% 20.67% 20.62% 19.43% 21.13%
0.15 0.21 0.87 0.16 0.96 -2.56 0.68 1.66 0.64
Interest 9.45 6.32 5.90 6.28 6.29 5.15 5.06 4.25 6.00
Depreciation 4.60 4.60 4.51 4.69 4.64 4.66 4.67 4.75 4.69
Profit before tax -0.50 3.17 5.52 8.15 4.93 2.28 6.31 7.62 4.49
Tax % -28.00% 28.71% 22.64% 26.87% 28.80% 46.93% 26.47% 27.43% 26.28%
-0.36 2.26 4.28 5.96 3.51 1.21 4.63 5.53 3.31
EPS in Rs -0.13 0.78 1.48 2.07 1.22 0.31 1.19 1.42 0.85
Raw PDF

Profit & Loss

Figures in Rs. Crores

Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026 TTM
184 171 225 259 280 275 288 291
147 133 173 206 223 215 228 232
Operating Profit 37 38 52 53 58 60 60 60
OPM % 20% 22% 23% 20% 21% 22% 21% 20%
2 1 76 4 1 1 1 0
Interest 38 40 49 35 34 28 21 20
Depreciation 16 17 17 18 20 18 19 19
Profit before tax -15 -18 62 3 5 15 21 21
Tax % 25% 23% 11% 179% 32% 29% 30%
-19 -22 55 -2 4 10 15 15
EPS in Rs -7.03 -8.14 20.54 -0.79 1.35 3.64 3.83 3.77
Dividend Payout % 0% 0% 0% 0% 0% 0% 0%
Compounded Sales Growth
10 Years: %
5 Years: 11%
3 Years: 4%
TTM: 7%
Compounded Profit Growth
10 Years: %
5 Years: 22%
3 Years: 114%
TTM: -4%
Stock Price CAGR
10 Years: %
5 Years: %
3 Years: %
1 Year: %
Return on Equity
10 Years: %
5 Years: 4%
3 Years: 10%
Last Year: 10%

Balance Sheet

Figures in Rs. Crores

Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
Equity Capital 27 27 27 27 27 29 39
Reserves 2 -20 36 36 39 68 181
231 235 226 216 211 204 244
127 150 104 96 75 81 93
Total Liabilities 388 392 392 374 352 382 558
244 242 240 232 228 217 207
CWIP 0 0 0 9 0 7 82
Investments 0 2 3 0 4 8 7
144 149 149 133 120 150 262
Total Assets 388 392 392 374 352 382 558

Cash Flows

Figures in Rs. Crores

Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
38 31 62 43 58 47 48
-9 -13 -6 -7 -10 -24 -94
-37 -18 -50 -42 -46 -23 126
Net Cash Flow -8 -0 6 -6 1 -1 81
Free Cash Flow 27 19 52 36 46 26 -32
CFO/OP 102% 66% 119% 93% 111% 84% 93%

Ratios

Figures in Rs. Crores

Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
Debtor Days 104 110 73 75 63 67 55
Inventory Days 225 422 338 247 309 464 312
Days Payable 99 186 185 130 129 194 136
Cash Conversion Cycle 229 345 226 193 243 336 231
Working Capital Days 51 -5 28 42 16 26 6
ROCE % 9% 14% 13% 14% 15% 12%

Insights

In beta
Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
Capacity Utilization - LVP (excl. SteriPort)
%

Log in to view insights

Please log in to see hidden values.

Login
Capacity Utilization - SteriPort
%
Installed Capacity - SteriPort (LVP)
Crore bottles per year
Installed Capacity - SVP
Crore bottles per year
Active Export Countries
count
Product Portfolio
count
International Product Registration Jurisdictions
count
Number of Distributors & Stockists
count

Extracted by Screener AI

Shareholding Pattern

Numbers in percentages

12 Recently
Sep 2025Dec 2025Mar 2026Jun 2026
63.56% 63.56% 63.72% 63.79%
1.00% 1.10% 0.85% 0.43%
11.34% 11.24% 12.88% 12.92%
24.10% 24.09% 22.55% 22.84%
No. of Shareholders 18,66916,18115,22212,612

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents

Announcements

Annual reports

No data available.

DRHP

Credit ratings

Concalls